Cipla gets USFDA nod for migraine drug

The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3sGLvmo
via IFTTT

0 comments:

Post a Comment